Effect of Four-Week Wellness Program on Work Engagement Burnout and Sleep in a Healthcare Organization (WEBS)

Not Applicable

Completed

• Conditions: Sleep; Work Engagement; Burnout

• Registration Number: NCT06779526
• Lead Sponsor: WellSpan Health

Brief Summary

The goal of this clinical trial is to learn if having a 4-week heartfulness meditation program in a healthcare organization would

1. decrease burnout

2. improve sleep and work engagement.

Researchers will compare : intervention group : participating in 4 weeks of Heartfulness Meditation with control group: receiving no intervention

Responses to the Utrecht Work Engagement Scale (UWES), Bergen Insomnia Scale (BIS) and two burnout questions will be compared between the study groups at the beginning and end of the intervention period.

Detailed Description

The study is an 8-week single-center prospective, randomized, crossover study among healthcare workers in the WellSpan Health System. All participants were asked to answer two demographic questions and responses to the Utrecht Work Engagement Scale (UWES), and Bergen Insomnia Scale (BIS), two burnout questions were requested for a baseline. Participants were randomized to two groups. One of the groups would undergo the intervention first, which comprised receiving an orientation session regarding the study, attending at least once weekly didactic sessions on Zoom, and participating in morning and evening meditation for ten to fifteen minutes daily. The duration of the intervention period was four weeks. During this time, the control group would not be undergoing any intervention. After four weeks, both groups completed the original questionnaire again followed by a 2 week washout period. This was followed by a crossover, allowing the second group to undergo the intervention for four weeks. After four weeks, the final survey was sent to all participants again.

Study Timeline

• Study Start: 2024-05-08
• Primary Completion: 2024-08-08
• Study Completion: 2024-08-31
• Status Verified: 2025-01
• Study First Submitted: 2025-01-11
• Study First Submitted QC: 2025-01-11
• Last Update Submitted: 2025-01-11
• Study First Posted: 2025-01-16
• Last Update Posted: 2025-01-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

• Age above 18 and willing to participate
• Able to understand the English language as the instructions were in English

Exclusion Criteria

• Not able to understand English language

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Sleep	From intervention to end of intervention at 4 weeks for each group	The Bergen Insomnia Scale (BIS) was measured prior to enrollment, at the four-week time point after the first half of the study, and at the end of the study period at 8 weeks for both the groups. The BIS contains six questions relating to sleep and tiredness, and it is scaled based on the number of days per week that participants are experiencing symptoms. 0 means no days during the course of a week, and 7 indicates every day of the week.

Secondary Outcome Measures

Name	Time	Method
Work engagement	From intervention to end of intervention at 4 weeks for each group	THE UWES scale, designed to study work engagement using three scales: vigor, dedication, and absorption was measured prior to the beginning of the study, at the four-week time point after the first half of the study, and at the end of the study period at 8 weeks for both groups. The UWES questionnaire contains 9 questions, and participants are given a scale from 0 to 6, with 0 being never to 6 being always 10.
Burnout	From intervention to end of intervention at 4 weeks for each group	Two burnout questions were asked, 1. I feel burned out from my work 2. I have become more callous toward people since I took this job . The scale for answering these questions ranged from never to everyday. This was measured prior to the beginning of the study, at the four-week time point after the first half of the study, and at the end of the study period at 8 weeks for both groups.

Trial Locations

Locations (1)

WellSpan Health; 🇺🇸 York, Pennsylvania, United States